1 | read more » november | | | | | | | 3 | 0.49% |
2 | insertion of a pressure | | | | | | | 2 | 0.33% |
3 | icp measurement company has | | | | | | | 2 | 0.33% |
4 | of a pressure sensor | | | | | | | 2 | 0.33% |
5 | a pressure sensor into | | | | | | | 2 | 0.33% |
6 | innovate uk biomedical catalyst | | | | | | | 2 | 0.33% |
7 | pressure sensor into the | | | | | | | 2 | 0.33% |
8 | november 14 2023 crainio | | | | | | | 2 | 0.33% |
9 | » november 14 2023 | | | | | | | 2 | 0.33% |
10 | of icp is through | | | | | | | 2 | 0.33% |
11 | measurement of icp is | | | | | | | 2 | 0.33% |
12 | intracranial pressure icp measurement | | | | | | | 2 | 0.33% |
13 | pressure icp measurement company | | | | | | | 2 | 0.33% |
14 | » november 8 2022 | | | | | | | 2 | 0.33% |
15 | more » november 8 | | | | | | | 2 | 0.33% |
16 | more » november 14 | | | | | | | 2 | 0.33% |
17 | low power infra red | | | | | | | 2 | 0.33% |
18 | power infra red light | | | | | | | 2 | 0.33% |
19 | significant grant from the | | | | | | | 2 | 0.33% |
20 | our technology company status | | | | | | | 2 | 0.33% |
21 | focus our technology company | | | | | | | 2 | 0.33% |
22 | company focus our technology | | | | | | | 2 | 0.33% |
23 | home company focus our | | | | | | | 2 | 0.33% |
24 | light at the scalp | | | | | | | 2 | 0.33% |
25 | clinical utility and accuracy | | | | | | | 1 | 0.16% |
26 | utility and accuracy of | | | | | | | 1 | 0.16% |
27 | skip to content home | | | | | | | 1 | 0.16% |
28 | demonstrate the clinical utility | | | | | | | 1 | 0.16% |
29 | the clinical utility and | | | | | | | 1 | 0.16% |
30 | accuracy of the technology | | | | | | | 1 | 0.16% |
31 | being set up to | | | | | | | 1 | 0.16% |
32 | are being set up | | | | | | | 1 | 0.16% |
33 | studies are being set | | | | | | | 1 | 0.16% |
34 | clinical studies are being | | | | | | | 1 | 0.16% |
35 | device clinical studies are | | | | | | | 1 | 0.16% |
36 | medical device clinical studies | | | | | | | 1 | 0.16% |
37 | a medical device clinical | | | | | | | 1 | 0.16% |
38 | as a medical device | | | | | | | 1 | 0.16% |
39 | developed as a medical | | | | | | | 1 | 0.16% |
40 | crainio is currently being | | | | | | | 1 | 0.16% |